ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joseph M. Arcidi, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Millar, R. C.
Right arrow Articles by Alison, P. J.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Millar, R. C.
Right arrow Articles by Alison, P. J.M.

Ann Thorac Surg 2000;70:1580-1586
© 2000 The Society of Thoracic Surgeons


Original articles: cardiovascular

The maze III procedure for atrial fibrillation: should the indications be expanded?

Roger C. Millar, MDa, Joseph M. Arcidi, Jr, MDa, Peter J.M. Alison, MDa

a Division of Cardiovascular and Thoracic Surgery, LDS Hospital, Salt Lake City, Utah, USA

Address reprint requests to Dr Millar, Salt Lake Cardiovascular and Thoracic Surgery, 324 Tenth Ave, Suite 160, Salt Lake City, UT 84103

Background. We favor the maze III procedure over nonsurgical treatments for atrial fibrillation and have advocated addition of the maze in symptomatic patients with other compelling indications for cardiac surgery.

Methods. Characteristics and perioperative outcomes of our 76 cumulative maze recipients between 1993 to 1998 were reviewed. The original maze III technique was employed without modification.

Results. Isolated maze III was performed in 19 patients (25%) and combined with other procedures in 57 patients (75%), 49 of these involving one or more valves. Patients having combined procedures were taking fewer antiarrhythmics (p < 0.0001), but were older (p < 0.01), more often female (p < 0.05), and more often had chronic atrial fibrillation (p < 0.01) compared with isolated maze III recipients. The mean duration of aortic clamping and cardiopulmonary bypass for isolated maze was 69 ± 11 and 145 ± 22 minutes, and for combined valve procedures it was 122 ± 38 and 205 ± 47 minutes. There was no operative mortality. Complications occurred in 15 patients (19.7%). At 3 months atrial fibrillation was cured in 73 of 75 patients (97.3%). Sick sinus syndrome required pacemaker implantation in 3 patients (4.0%).

Conclusions. The maze III can be performed alone or as a combined procedure with equivalent success, and technical modifications may be unnecessary. A lower threshold for its expanded use in symptomatic patients with atrial fibrillation who require isolated or combined operations is appropriate.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
W. P. Beukema, H. T. Sie, A. R. R. Misier, P. P. Delnoy, H. J.J. Wellens, and A. Elvan
Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure
Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 771 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. R. Doty, D. B. Doty, K. W. Jones, J. H. Flores, M. Mensah, B. B. Reid, S. E. Clayson, G. Snow, E. Righter, and R. C. Millar
Comparison of standard Maze III and radiofrequency Maze operations for treatment of atrial fibrillation
J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1037 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M.-J. Baek, C.-Y. Na, S.-S. Oh, C.-H. Lee, J. H. Kim, H. J. Seo, S.-W. Park, and W. S. Kim
Surgical treatment of chronic atrial fibrillation combined with rheumatic mitral valve disease: effects of the cryo-maze procedure and predictors for late recurrence
Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 728 - 736.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Ad, S. Barnett, E. A. Lefrak, A. Korach, A. Pollak, D. Gilon, and A. Elami
Impact of follow-up on the success rate of the cryosurgical maze procedure in patients with rheumatic heart disease and enlarged atria
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1073 - 1079.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. L. Gaynor, R. B. Schuessler, M. S. Bailey, Y. Ishii, J. P. Boineau, M. J. Gleva, J. L. Cox, and R. J. Damiano Jr
Surgical treatment of atrial fibrillation: Predictors of late recurrence
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 104 - 111.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Khargi, B. Lemke, H. Haardt, K.-M. Muller, A. Mugge, A. Laczkovics, and T. Deneke
Concomitant anti-arrhythmic surgery, using irrigated cooled-tip radiofrequency ablation, to treat permanent atrial fibrillation in CABG patients: expansion of the indication?
Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 1018 - 1024.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
G. Shanmugam and M. Bayfield
Integrated procedure for giant right coronary aneurysm with fistula and atrial fibrillation - coronary grafting, fistula obliteration and radiofrequency maze
Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 168 - 170.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
K. Khargi, T. Deneke, B. Lemke, and A. Laczkovics
Irrigated radiofrequency ablation is a safe and effective technique to treat chronic atrial fibrillation
Interactive CardioVascular and Thoracic Surgery, September 1, 2003; 2(3): 241 - 245.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. W. Mohr, A. M. Fabricius, V. Falk, R. Autschbach, N. Doll, U. von Oppell, A. Diegeler, H. Kottkamp, and G. Hindricks
Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: Short-term and midterm results
J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 919 - 927.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Jais, R. Weerasooriya, D. C. Shah, M. Hocini, L. Macle, K.-J. Choi, C. Scavee, M. Haissaguerre, and J. Clementy
Ablation therapy for atrial fibrillation (AF): Past, present and future
Cardiovasc Res, May 1, 2002; 54(2): 337 - 346.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.